These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 21703956)

  • 21. Cinacalcet de novo in persistent hypercalcemia after kidney transplantation secondary to hyperparathyroidism: long-term follow-up and effect of withdrawal.
    Paschoalin RP; Torregrosa JV; Barros X; Durán CE; Campistol JM
    Transplant Proc; 2012 Oct; 44(8):2376-8. PubMed ID: 23026597
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of cinacalcet hydrochloride on bone histology in patients with secondary hyperparathyroidism.
    Yajima A; Akizawa T; Tsukamoto Y; Kurihara S; Ito A;
    Ther Apher Dial; 2008 Oct; 12 Suppl 1():S38-43. PubMed ID: 19032526
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An assessment of cinacalcet HCl effects on bone histology in dialysis patients with secondary hyperparathyroidism.
    Malluche HH; Monier-Faugere MC; Wang G; Frazã O JM; Charytan C; Coburn JW; Coyne DW; Kaplan MR; Baker N; McCary LC; Turner SA; Goodman WG
    Clin Nephrol; 2008 Apr; 69(4):269-78. PubMed ID: 18397701
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Therapeutic agents for disorders of bone and calcium metabolism. The calcimimetic cinacalcet HCl].
    Nakanishi S; Fukagawa M
    Clin Calcium; 2007 Jan; 17(1):88-92. PubMed ID: 17211098
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cinacalcet chloride is efficient and safe in renal transplant recipients with posttransplant hyperparathyroidism.
    Szwarc I; Argilés A; Garrigue V; Delmas S; Chong G; Deleuze S; Mourad G
    Transplantation; 2006 Sep; 82(5):675-80. PubMed ID: 16969292
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of cinacalcet cessation in renal transplant recipients with persistent hyperparathyroidism.
    Kruse AE; Eisenberger U; Frey FJ; Mohaupt MG
    Nephrol Dial Transplant; 2007 Aug; 22(8):2362-5. PubMed ID: 17510094
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early and severe hyperparathyroidism associated with hypercalcemia after renal transplant treated with cinacalcet.
    Leca N; Laftavi M; Gundroo A; Kohli R; Min I; Karam J; Sridhar N; Blessios G; Venuto R; Pankewycz O
    Am J Transplant; 2006 Oct; 6(10):2391-5. PubMed ID: 16869807
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cinacalcet for the treatment of primary hyperparathyroidism.
    Sajid-Crockett S; Singer FR; Hershman JM
    Metabolism; 2008 Apr; 57(4):517-21. PubMed ID: 18328354
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment with cinacalcet of secondary hyperparathyroidism after renal transplantation.
    Gómez Marqués G; Obrador Mulet A; Vilar Gimeno A; Pascual Felip MJ; Alarcón Zurita A; Molina Guasch M; Uriol Rivera M; Munar Vila MA; Losada González P
    Transplant Proc; 2009; 41(6):2139-43. PubMed ID: 19715856
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term clinical practice experience with cinacalcet for treatment of hypercalcemic hyperparathyroidism after kidney transplantation.
    Thiem U; Gessl A; Borchhardt K
    Biomed Res Int; 2015; 2015():292654. PubMed ID: 25861621
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of persistent hyperparathyroidism in renal transplant patients with cinacalcet improves control of blood pressure.
    Carrasco FR; Pérez-Flores I; Calvo N; Ridao N; Sánchez A; Barrientos
    Transplant Proc; 2009; 41(6):2385-7. PubMed ID: 19715927
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of cinacalcet in renal transplant patients with hyperparathyroidism.
    Courbebaisse M; Diet C; Timsit MO; Mamzer MF; Thervet E; Noel LH; Legendre C; Friedlander G; Martinez F; Prié D
    Am J Nephrol; 2012; 35(4):341-8. PubMed ID: 22473131
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The calcimimetic cinacalcet normalizes serum calcium in renal transplant patients with persistent hyperparathyroidism.
    Kruse AE; Eisenberger U; Frey FJ; Mohaupt MG
    Nephrol Dial Transplant; 2005 Jul; 20(7):1311-4. PubMed ID: 15941846
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cinacalcet HCl: a novel treatment for secondary hyperparathyroidism caused by chronic kidney disease.
    Torres PU
    J Ren Nutr; 2006 Jul; 16(3):253-8. PubMed ID: 16825031
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Decrease in serum tacrolimus level and rise in serum creatinine under late addition of cinacalcet in a renal transplant recipient with hyperparathyroidism: a case report.
    Maass E; Mueller GA; Heller T; Koziolek MJ
    Transplant Proc; 2007 Dec; 39(10):3468-70. PubMed ID: 18089410
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Treatment of secondary hyperparathyroidism resistant to conventional therapy and tertiary hyperparathyroidism with Cinacalcet: an efficiency strategy].
    Jean G; Vanel T; Terrat JC; Hurot JM; Lorriaux C; Mayor B; Deleaval P; Vovan C; Chazot C
    Nephrol Ther; 2010 Apr; 6(2):105-10. PubMed ID: 20185380
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cinacalcet for hypercalcaemic secondary hyperparathyroidism after renal transplantation: a multicentre, retrospective, 3-year study.
    Torregrosa JV; Morales E; Díaz JM; Crespo J; Bravo J; Gómez G; Gentil MÁ; Rodríguez Benot A; García MR; Jiménez VL; Gutiérrez Dalmau A; Jimeno L; Sáez MJ; Romero R; Gómez Alamillo C;
    Nephrology (Carlton); 2014 Feb; 19(2):84-93. PubMed ID: 24428216
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mineral metabolism in renal transplant recipients discontinuing cinacalcet at the time of transplantation: a prospective observational study.
    Evenepoel P; Sprangers B; Lerut E; Bammens B; Claes K; Kuypers D; Meijers B; Vanrenterghem Y
    Clin Transplant; 2012; 26(3):393-402. PubMed ID: 22007637
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Long-term efficacy and safety of treatment with cinacalcet in hypercalcemic persistent secondary hyperparathyroidism in renal transplant].
    Massimetti C; Di Napoli A; Feriozzi S
    G Ital Nefrol; 2022 Jun; 39(3):. PubMed ID: 35819043
    [No Abstract]   [Full Text] [Related]  

  • 40. Treatment with cinacalcet in 29 kidney transplant patients with persistent hyperparathyroidism.
    López V; Toledo R; Sola E; Gutiérrez C; Sujan S; Rodríguez MA; Cabello M; Burgos D; González Molina M; Hernández D
    Transplant Proc; 2009; 41(6):2394-5. PubMed ID: 19715930
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.